Lenvatinib Mesylate

Lenvatinib Mesylate is a synthetic, orally available tyrosine kinase inhibitor that inhibits vascular endothelial growth factor receptor (VEGFR1-3), fibroblast growth factor receptor (FGFR1-4), platelet-derived growth factor receptor α (PDGFRα), stem cell factor receptor (Kit (c-Kit)), and rearranged during transfection (RET (c-RET)). Lenvatinib Mesylate has potential antineoplastic activity.

Price Not Available 25mg Lenvatinib Mesylate Supplier Page

Trivial name	E7080 mesylate
Catalog Number	S5240
Molecular Formula	C21H19ClN4O4.CH4O3S
CAS#	857890-39-2
Inchi	InChI=1S/C21H19ClN4O4.CH4O3S/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11;1-5(2,3)4/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28);1H3,(H,2,3,4)
Inchi Key	HWLFIUUAYLEFCT-UHFFFAOYSA-N
SMILES	COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl.CS(=O)(=O)O
Size	25mg
Supplier Page	http://www.selleckchem.com/products/lenvatinib-mesylate.html
Additional Information	https://file.selleck.cn/downloads/struct/lenvatinib-mesylate-chemical-structure-s5240.gif